# Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis

> **NCT07378761** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 94 (estimated)

## Conditions studied

- Immune-Mediated Cholestasis

## Interventions

- **DRUG:** UDCA (Ursodeoxycholic acid)
- **DRUG:** Corticosteroids (Reference Treatment)

## Key facts

- **NCT ID:** NCT07378761
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-09
- **Final completion:** 2028-08
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07378761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07378761, "Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07378761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*